| ¿µ¹® | serum proteins | ÇÑ±Û | Ç÷û´Ü¹é |
|---|---|---|---|
| ¼³¸í | Ç÷û¿¡ ÀÖ´Â ´Ü¹éÁúµéÀ» ÃÑĪÇÏ´Â ¸»·Î, ¸é¿ª±Û·ÎºÒ¸°(¸é¿ªÇö»ó¿¡ °ü¿©ÇÏ´Â Ç×ü¸¦ Çü¼ºÇÔ), ¾ËºÎ¹Î, º¸Ã¼ ¹× ÀÀ°íÀÎÀÚ¿Í ¿©·¯ È¿¼ÒµéÀÌ ÀÌ¿¡ ¼ÓÇÑ´Ù. |
||
| ¿µ¹® | basement membrane | ÇÑ±Û | ¹Ù´Ú¸·, ±âÀú¸· |
|---|---|---|---|
| ¼³¸í | »óÇǼ¼Æ÷, ±ÙÀ°¼¼Æ÷, ½Å°æÁ¶Á÷°ú ±×°ÍµéÀÇ ¹Ù±ùÂÊ °áÇÕÁ¶Á÷ÀÇ °æ°è¿¡ ÀÖ´Â Á¡¾×´Ù´çÁú°ú ´Ü¹éÁú·Î ±¸¼ºµÈ ¾ãÀº ¸·. ±âÃʸ· ¶Ç´Â °æ°è¸·À̶ó°íµµ ÇÑ´Ù. µÎ²²´Â 50~80nmÀÌ´Ù. ±âÀú¸·Àº 20~30nm °£°ÝÀ¸·Î ´Ã¾î¼± Á·¼¼Æ÷·Î µÈ »óÇǼ¼Æ÷ÀÇ 3ÃþÀ¸·Î µÇ¾î ÀÖ°í, ºÐÀÚ·® 40,000~60,000ÀÇ ¹°ÁúÀ» Åõ°úÇÒ ¼ö ÀÖ°Ô ÇÑ´Ù. ¶ÇÇÑ Ç¥ÇÇ¿Í ÁøÇÇÀÇ °æ°è·Î ¿µ¾çÀ» °ø±ÞÇÏ´Â ±âÁö ¿ªÇÒÀ» ÇÑ´Ù. ÁÖ·Î ¼¶À¯¸¦ Æ÷ÇÔÇÏ¿© ´Ù´ç·ù·Î µÇ¾î Àִµ¥, ÇöÀúÇÏ°Ô ¹ß´ÞµÇ¾î ÀÖ´Â ºÎºÐ°ú ±×·¸Áö ¾ÊÀº ºÎºÐÀÌ ÀÖ´Ù. ºñÁ¡¸·¿¡¼´Â Á¡¸·»óÇÇÀÇ ¹Ø¿¡ ¹ß´ÞÇÑ ±âÀú¸·ÀÌ ÀÖ´Ù. ÀÌ ¸· À§¿¡ û°¢¼ö¿ë¼¼Æ÷ÀÎ Åм¼Æ÷¸¦ °®´Â ÄÚ¸£Æ¼±â°üÀÌ Á¸ÀçÇÑ´Ù. ±âÀú¸·Àº ÀüÁ¦°¡ À½Àü±â ¼ºÁúÀ» °¡Áö°í ÀÖ¾î ¾çÀü±â¸¦ °¡Áø ¹°ÁúÀÌ Åõ°úÇϱ⠽±´Ù. ±âÀú¸·ÀÌ ÆØÈÇϰųª ¹Ðµµ°¡ ³·¾ÆÁö¸é ´Ü¹éÁúÀÌ Åë°úÇÏ¿© ´Ü¹é´¢¸¦ ÀÏÀ¸Å°°í, ±âÀú¸·¿¡ ±Õ¿-ÆÄ±« µîÀÌ ÀϾ¸é ÀûÇ÷±¸ µîÀÇ Ç÷¾× °íÇü¼ººÐÀÌ Åõ°úÇÏ¿© Ç÷´¢°¡ µÈ´Ù. |
||
| ¿µ¹® | hyaline membrane disease | ÇÑ±Û | À¯¸®Áú¸·º´ |
|---|---|---|---|
| ¼³¸í | ÇãÆÄ ¼º¼÷µµÀÇ ¹Ì¼÷À¸·Î ÇãÆÄ²Ê¸®¸¦ ÆØÃ¢½ÃŰ´Â ¹°Áú(Ç¥¸éȰ¼ºÁ¦)ÀÌ ºÎÁ·ÇÏ¿© È£Èí°ï¶õÀÌ ÃÊ·¡µÇ´Â º´À¸·Î¼ ¹Ì¼÷¾Æ¿¡ È£¹ßÇϴµ¥, Ãâ»ý½Ã ÀӽűⰣº¸´Ùµµ ÇãÆÄ ¼º¼÷ Á¤µµ°¡ ´õ °ü¿©µÈ´Ù. ´ÜÀÏ º´À¸·Î¼´Â »ç¸Á·üÀÌ °¡Àå ³ôÀ¸¸ç(¾à 30%), ½Å»ý¾ÆÀÇ ´ëÇ¥ÀûÀÎ º´ÀÌ´Ù. ÀÓ»óÀûÀ¸·Î´Â ¹Ì¼÷¾Æ, »ýÈÄ 6~8½Ã°£³» È£Èí°ï¶õÁõ¼¼ ÃâÇö°ú »ýÈÄ 24~48½Ã°£ÀÇ Áõ»ó ¾ÇÈ, »ýÈÄ 2~3Àϰ£ ÀΰøÀûÀ¸·Î »ê¼Ò¸¦ °ø±ÞÇÏÁö ¾ÊÀ¸¸é È£ÈíÀ» °è¼Ó½Ãų ¼ö°¡ ¾øÀ¸¸ç Á¡Á¡´õ »ê¼ÒÀÇ °ø±Þ ÀÇÁ¸µµ°¡ ³ô¾ÆÁö¸ç, µ¿¸ÆÇ÷¾×¼ÓÀÇ »ê¼Ò³óµµ°¡ ³»·Á°¡°í ÀÌ»êÈź¼ÒÀÇ ³óµµ°¡ ³ôÀ¸¸ç, ÈäºÎ ¹æ»ç¼± ¼Ò°ßÀ» ÂüÀÛÇÏ¿© Áø´ÜÇÑ´Ù. ȯ¾Æ´Â ¼÷·ÃµÈ °£È£ Àη°ú ÷´Ü ÀÇ·á Àåºñ°¡ ¼³Ä¡µÈ ½Å»ý¾Æ ÁýÁß Ä¡·á½Ç¿¡¼ Ä¡·áÇÏ¿©¾ß ÇÑ´Ù. ¿¹ÈÄ´Â Áõ¼¼ÀÇ °æÁß¿¡ µû¶ó ´Ù¸£°í »ç¸Á·üÀº 30~50% µÈ´Ù. ¾î¶² ¾Æ±â¿¡ À־ ġ·á ÈÄ¿¡ ´«À̳ª ±â°üÁöÇãÆÄ °èÅë¿¡ Àå¾Ö¸¦ ÀÏÀ¸Å°´Â »ê¼ÒÁßµ¶ÁõÀÌ º¸°íµÇ°í ÀÖ´Ù. |
||
| ¿µ¹® | plasma membrane | ÇÑ±Û | ÇüÁú¸· |
|---|---|---|---|
| ¼³¸í | ¿øÇüÁú Ç¥¸éÀ» µ¤´Â ¿¯Àº¸·. µÎ²²´Â 5~25¥ìmÀÌ´Ù. ±¤ÇÐÇö¹Ì°æÀ¸·Î´Â °üÂûÇÒ ¼ö ¾øÁö¸¸ ÀüÀÚÇö¹Ì°æÀ¸·Î °üÂûÀÌ °¡´ÉÇÏ´Ù. ¿øÇüÁú¸·ÀÇ ºÐÀÚ±¸Á¶´Â ·¹½ÃƾÀ̳ª ÄÝ·¹½ºÅ×·Ñ µîÀÇ Ç¥¸é Ȱ¼º¹°Áú ºÐÀÚ°¡ 2ºÐÀÚÃþÀ¸·Î ±× Ç¥¸é¿¡ ¹è¿µÇ¸ç, À̰ÍÀ» °¢ 1ºÐÀÚÃþÀÇ ´Ü¹éÁú ºÐÀÚ°¡ ¾çÂÊ¿¡¼ »÷µåÀ§Ä¡ÇÑ ´ÜÀ§¸· ±¸Á¶ÀÌ´Ù. ÀüÀÚÇö¹Ì°æÀûÀ¸·Î ÀÌ ´ÜÀ§´Â ¾Ï-¸í-¾ÏÀÇ 3Ãþ(°¢ ¾à 20nm)À¸·Î ±¸º°µÈ´Ù. ¿øÇüÁúÀÇ Åõ°ú¼º¿¡ Áß¿äÇÑ ±¸½ÇÀ» Çϸç, »ý¸®»óŰ¡ º¯ÇÏ¸é ±× Åõ°ú¼ºµµ ½Å¼ÓÈ÷ º¯ÇÑ´Ù. ¶Ç, ¼Õ»óÀÌ µÇ¸é ½±°Ô »õ·Î Çü¼ºµÈ´Ù. |
||
| CFF | critical flicker fusion [test]; critical fusion frequency; cystic fibrosis factor; Cystic Fibrosis F... |
|---|---|
| cff | critical flicker fusion; critical fusion frequency |
| MF | magnetic field; meat free; medium frequency; megafarad; membrane filler; merthiolate-formaldehyde [s... |
| SCM | Schwann cell membrane; sensation, circulation, and motion; Society of Computer Medicine; soluble cyt... |
| PBPs | Penicillin-Binding Proteins |
| G proteins | GIP-binding proteins |
|---|---|
| G-proteins | GTP)-binding regulatory proteins |
| G-proteins | Guanine nucleotide-binding regulatory proteins |
| G proteins | reglatory proteins |
| MFP | membrane fusion protein |
| recombinant fusion proteins | Proteins that are the result of genetic engineering. A regulatory part or promoter of one or more genes is combined with a structural gene. The fusion protein is formed after transcription and translation of the fused gene. This type of fusion protein is used in the study of gene regulation or structure-activity relationships. They might also be used clinically as targeted toxins (immunotoxins). (12 Dec 1998) |
|---|---|
| viral fusion proteins | Proteins, usually glycoproteins, found in the viral envelopes of a variety of viruses. They promote cell membrane fusion and thereby may function in the uptake of the virus by cells. (12 Dec 1998) |
| oncogene proteins, fusion | The translation products of the fusion between an oncogene and another gene. The latter may be of viral or cellular origin. (12 Dec 1998) |
| fusion proteins, bcr-abl | Translation products of a fusion mRNA derived from the breakpoint cluster region (bcr) gene and a cellular abl (c-abl) gene translocated to chromosome 22. The p210(bcr-abl) fusion protein is found in patients with chronic myelogenous leukaemia. The p190(bcr-abl) fusion protein is found in patients with acute lymphocytic leukaemia. The activation of human c-abl by chromosomal translocation is essentially the same as the activation of murine c-abl by viral translocation in abelson murine leukaemia virus. (12 Dec 1998) |
| fusion proteins, gag-onc | General name for the translation products of a fusion mRNA consisting of a gag gene and a viral oncogene (v-onc). These products are thought to have the ability to transform cells. (12 Dec 1998) |
| fusion proteins, gag-pol | Polyprotein products of a fused portion of retroviral mRNA containing the gag and pol genes. The polyprotein is synthesised only five percent of the time since pol is out of frame with gag, and is generated by ribosomal frameshifting. (12 Dec 1998) |
| membrane fusion | The adherence of cell membranes, intracellular membranes, or artifical membrane models of either to each other or to viruses, parasites, or interstitial particles through a variety of chemical and physical processes. (12 Dec 1998) |
| bacterial outer membrane proteins | Proteins isolated from the outer membrane of bacteria. (12 Dec 1998) |
| membrane proteins | Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. (12 Dec 1998) |
| atrial fusion beat | A beat that occurs when the atria are activated in part by the sinus impulse and in part by an ectopic or retrograde impulse from A-V junction or ventricle. (05 Mar 2000) |
| magnetic confinement fusion | <physics> Method of fusion which uses magnetic fields / magnetic bottles to confine a hot plasma until fusion occurs. (09 Oct 1997) |
| gene fusion | Fusion of structural genes to analyze protein behaviour or fusion of regulatory sequences with structural genes to determine mechanisms of regulation. (12 Dec 1998) |
| ventricular fusion beat | A fusion beat that occurs when the ventricles are activated partly by the descending sinus or A-V junctional impulse and partly by an ectopic ventricular impulse. (05 Mar 2000) |
| vertebral fusion | A procedure that involves fusing together two or more vertebrae in the spine using either bone grafts or metal rods (Harrington rods). This procedure may be used to correct kyphosis or scoliosis. It is also used in those who require spine stabilisation due to vertebral damage from ruptures discs, fractures, osteomyelitis, osteoarthritis or tumour. (27 Sep 1997) |
| cell fusion | <biology, embryology> Fusion of two previously separate cells occurs naturally in fertilization and in the formation of vertebrate skeletal muscle, but can be induced artificially by the use of Sendai virus or fusogens such as polyethylene glycol. Fusion may be restricted to cytoplasm or nuclei may fuse as well. A cell formed by the fusion of dissimilar cells is often referred to as a heterokaryon. (26 Mar 1998) |
Synonyms : Fusion Proteins, Membrane, Proteins, Membrane Fusion
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|